AAAAAA

   
Results: 1-17 |
Results: 17
PHARMACOKINETICS OF AN ANTISENSE OLIGONUCLEOTIDE INJECTED INTRAVITREALLY IN MONKEYS
Authors: LEEDS JM HENRY SP BISTNER S SCHERRILL S WILLIAMS K LEVIN AA
Citation: Jm. Leeds et al., PHARMACOKINETICS OF AN ANTISENSE OLIGONUCLEOTIDE INJECTED INTRAVITREALLY IN MONKEYS, Drug metabolism and disposition, 26(7), 1998, pp. 670-675
EVALUATION OF THE TOXICITY OF ISIS-2302, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, IN A 4-WEEK STUDY IN CD-1 MICE
Authors: HENRY SP TAYLOR J MIDGLEY L LEVIN AA KORNBRUST DJ
Citation: Sp. Henry et al., EVALUATION OF THE TOXICITY OF ISIS-2302, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, IN A 4-WEEK STUDY IN CD-1 MICE, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(5), 1997, pp. 473-481
INHIBITION OF COAGULATION BY A PHOSPHOROTHIOATE OLIGONUCLEOTIDE
Authors: HENRY SP NOVOTNY W LEEDS J AULETTA C KORNBRUST DJ
Citation: Sp. Henry et al., INHIBITION OF COAGULATION BY A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(5), 1997, pp. 503-510
EFFECTS OF INTRAVENOUS-INFUSION OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES ON COAGULATION, COMPLEMENT ACTIVATION AND HEMODYNAMICS
Authors: HENRY SP MONTEITH D KORNBRUST DJ LEVIN AA
Citation: Sp. Henry et al., EFFECTS OF INTRAVENOUS-INFUSION OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES ON COAGULATION, COMPLEMENT ACTIVATION AND HEMODYNAMICS, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1673-1676
PHARMACOKINETIC PROPERTIES OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES
Authors: LEEDS JM GEARY RS HENRY SP GLOVER J SHANAHAN W FITCHETT J BURCKIN T TRUONG L LEVIN AA
Citation: Jm. Leeds et al., PHARMACOKINETIC PROPERTIES OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1689-1693
EVALUATION OF THE TOXICITY OF ISIS-2302, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, IN A 4-WEEK STUDY IN CYNOMOLGUS MONKEYS
Authors: HENRY SP BOLTE H AULETTA C KORNBRUST DJ
Citation: Sp. Henry et al., EVALUATION OF THE TOXICITY OF ISIS-2302, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, IN A 4-WEEK STUDY IN CYNOMOLGUS MONKEYS, Toxicology, 120(2), 1997, pp. 145-155
COMPARISON OF THE TOXICITY PROFILES OF ISIS-1082 AND ISIS-2105, PHOSPHOROTHIOATE OLIGONUCLEOTIDES, FOLLOWING SUBACUTE INTRADERMAL ADMINISTRATION IN SPRAGUE-DAWLEY RATS
Authors: HENRY SP GRILLONE LR ORR JL BRUNER RH KORNBRUST DJ
Citation: Sp. Henry et al., COMPARISON OF THE TOXICITY PROFILES OF ISIS-1082 AND ISIS-2105, PHOSPHOROTHIOATE OLIGONUCLEOTIDES, FOLLOWING SUBACUTE INTRADERMAL ADMINISTRATION IN SPRAGUE-DAWLEY RATS, Toxicology, 116(1-3), 1997, pp. 77-88
ANTISENSE OLIGONUCLEOTIDE INHIBITORS FOR THE TREATMENT OF CANCER .1. PHARMACOKINETIC PROPERTIES OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES
Authors: GEARY RS LEEDS JM HENRY SP MONTEITH DK LEVIN AA
Citation: Rs. Geary et al., ANTISENSE OLIGONUCLEOTIDE INHIBITORS FOR THE TREATMENT OF CANCER .1. PHARMACOKINETIC PROPERTIES OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES, Anti-cancer drug design, 12(5), 1997, pp. 383-393
ANTISENSE OLIGONUCLEOTIDE INHIBITORS FOR THE TREATMENT OF CANCER .2. TOXICOLOGICAL PROPERTIES OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES
Authors: HENRY SP MONTEITH D LEVIN AA
Citation: Sp. Henry et al., ANTISENSE OLIGONUCLEOTIDE INHIBITORS FOR THE TREATMENT OF CANCER .2. TOXICOLOGICAL PROPERTIES OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES, Anti-cancer drug design, 12(5), 1997, pp. 395-408
TOXICOLOGICAL AND PHARMACOKINETIC PROPERTIES OF CHEMICALLY-MODIFIED ANTISENSE OLIGONUCLEOTIDE INHIBITORS OF PKC-ALPHA AND C-RAF KINASE
Authors: HENRY SP MONTEITH D BENNETT F LEVIN AA
Citation: Sp. Henry et al., TOXICOLOGICAL AND PHARMACOKINETIC PROPERTIES OF CHEMICALLY-MODIFIED ANTISENSE OLIGONUCLEOTIDE INHIBITORS OF PKC-ALPHA AND C-RAF KINASE, Anti-cancer drug design, 12(5), 1997, pp. 409-420
IMMUNE STIMULATION - A CLASS EFFECT OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN RODENTS
Authors: MONTEITH DK HENRY SP HOWARD RB FLOURNOY S LEVIN AA BENNETT CF CROOKE ST
Citation: Dk. Monteith et al., IMMUNE STIMULATION - A CLASS EFFECT OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN RODENTS, Anti-cancer drug design, 12(5), 1997, pp. 421-432
TOXICOLOGICAL PROPERTIES OF SEVERAL NOVEL OLIGONUCLEOTIDE ANALOGS IN MICE
Authors: HENRY SP ZUCKERMAN JE ROJKO J HALL WC HARMAN RJ KITCHEN D CROOKE ST
Citation: Sp. Henry et al., TOXICOLOGICAL PROPERTIES OF SEVERAL NOVEL OLIGONUCLEOTIDE ANALOGS IN MICE, Anti-cancer drug design, 12(1), 1997, pp. 1-14
METABOLISM AND PHARMACOKINETICS OF FOMIVIRSEN-SODIUM (ISIS-2922) AFTER INTRAVITREAL INJECTION IN RABBITS AND MONKEYS
Authors: HENRY SP TROUNG L BURKIN T LEEDS JM
Citation: Sp. Henry et al., METABOLISM AND PHARMACOKINETICS OF FOMIVIRSEN-SODIUM (ISIS-2922) AFTER INTRAVITREAL INJECTION IN RABBITS AND MONKEYS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 687-687
PHARMACOKINETICS OF A POTENTIAL HUMAN CYTOMEGALOVIRUS THERAPEUTIC, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, AFTER INTRAVITREAL INJECTION IN THE RABBIT
Authors: LEEDS JM HENRY SP TRUONG L ZUTSHI A LEVIN AA KORNBRUST D
Citation: Jm. Leeds et al., PHARMACOKINETICS OF A POTENTIAL HUMAN CYTOMEGALOVIRUS THERAPEUTIC, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE, AFTER INTRAVITREAL INJECTION IN THE RABBIT, Drug metabolism and disposition, 25(8), 1997, pp. 921-926
ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY A PHOSPHOROTHIOATE OLIGONUCLEOTIDE - POTENTIAL MECHANISM OF ACTION
Authors: HENRY SP GICLAS PC LEEDS J PANGBURN M AULETTA C LEVIN AA KORNBRUST DJ
Citation: Sp. Henry et al., ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT BY A PHOSPHOROTHIOATE OLIGONUCLEOTIDE - POTENTIAL MECHANISM OF ACTION, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 810-816
CARDIAC-HYPERTROPHY IN RATS AFTER INTRAVENOUS ADMINISTRATION OF CI-959, A NOVEL ANTIINFLAMMATORY COMPOUND - MORPHOLOGIC FEATURES AND PHARMACOKINETIC AND PHARMACODYNAMIC MECHANISMS
Authors: LOW JE METZ AL MERTZ TE HENRY SP KNOWLTON P LOEWEN G SOMMERS CS ROBERTSON DG OLSZEWSKI BJ SCHROEDER RL GOUGH AW KEISER J MANN D
Citation: Je. Low et al., CARDIAC-HYPERTROPHY IN RATS AFTER INTRAVENOUS ADMINISTRATION OF CI-959, A NOVEL ANTIINFLAMMATORY COMPOUND - MORPHOLOGIC FEATURES AND PHARMACOKINETIC AND PHARMACODYNAMIC MECHANISMS, Journal of cardiovascular pharmacology, 25(6), 1995, pp. 930-939
PURIFICATION AND CHARACTERIZATION OF BOVINE HEART GLYCOGEN-SYNTHASE KINASE-3
Authors: HENRY SP KILLILEA SD
Citation: Sp. Henry et Sd. Killilea, PURIFICATION AND CHARACTERIZATION OF BOVINE HEART GLYCOGEN-SYNTHASE KINASE-3, Preparative biochemistry, 24(3-4), 1994, pp. 263-277
Risultati: 1-17 |